1. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

   • Ricardo Augusto Leoni De Sousa
   • Alex Cleber Improta-Caria

   Review Article 25 January 2022 Pages: 559 - 580

   

2. Alzheimer’s disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels

   • Xian-Tao Li

   Review Article 31 January 2022 Pages: 581 - 587

   

3. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy —current validation level and practical use

   • Mads Kingo Guldberg Hansen
   • Kristoffer Kjærgaard
   • Mette Munk Enok Lauridsen

   Review Article 01 February 2022 Pages: 589 - 605

4. Sesamol prevents mitochondrial impairment and pro-inflammatory alterations in the human neuroblastoma SH-SY5Y cells: role for Nrf2

   • Sônia Mendes da Silva Navarro
   • Fhelipe Jolner Souza de Almeida
   • Marcos Roberto de Oliveira

   Original Article 09 January 2022 Pages: 607 - 617

   

5. The association of stem cell factor and soluble c-Kit (s-cKit) receptor serum concentrations with the severity and risk prediction of autism spectrum disorders

   • Farhad Mashayekhi
   • Somayeh Shabani
   • Zivar Salehi

   Original Article 13 January 2022 Pages: 619 - 624

   

6. The brain neuropeptides and STAT3 mediate the inhibitory effect of 17-β Estradiol on central leptin resistance in young but not aged female high-fat diet mice

   • Zeinab Farhadi
   • Mohammad Khaksari
   • Shahriar Dabiri

   Original Article 15 January 2022 Pages: 625 - 637

   

7. Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer’s disease

   • Sharay E. Setti
   • Nikita Das
   • Sumit Sarkar

   Original Article 22 January 2022 Pages: 639 - 651

   

8. LncRNA NEAT1 ameliorate ischemic stroke via promoting Mfn2 expression through binding to Nova and activates Sirt3

   • Zhi-Wen Zhou
   • Xiang Ren
   • Wen-Sheng Zhou

   Original Article 24 January 2022 Pages: 653 - 664

   

9. Analysis of expression profiles and bioinformatics suggests that plasma exosomal circular RNAs may be involved in ischemic stroke in the Chinese Han population

   • Bingyi Xu
   • Xianli Huang
   • Li Su

   Original Article 24 January 2022 Pages: 665 - 676

   

10. LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis

    • Jun Peng
    • Zheng-Tao Yu
    • Ying Xia

    Original Article 28 January 2022 Pages: 677 - 688

    

11. Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease

    • Mohaddeseh Sadat Alavi
    • Sahar Fanoudi
    • Hamid R. Sadeghnia

    Original Article 31 January 2022 Pages: 689 - 700

    

12. Apelin–13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male rats

    • Sara Gazmeh
    • Maryam Azhir
    • Seyed Behnamedin Jameie

    Original Article 04 January 2022 Pages: 701 - 709

    

13. A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol

    • Mustafa Nazıroğlu

    Original Article 06 January 2022 Pages: 711 - 728

    

14. Effect of Solanum vegetables on memory index, redox status, and expressions of critical neural genes in Drosophila melanogaster model of memory impairment

    • Opeyemi B. Ogunsuyi
    • Olawande C. Olagoke
    • João B. T. da Rocha

    Original Article 07 January 2022 Pages: 729 - 741

    

15. Disorders of Tetrahydrobiopterin Metabolism: Experience from South India

    • Somdattaa Ray
    • Hansashree Padmanabha
    • S. R. Chandra

    Original Article 08 January 2022 Pages: 743 - 760

    

16. Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer’s disease progression.

    • Fardin Nabizadeh
    • Mahsa Pourhamzeh
    • ADNI

    Original Article 11 January 2022 Pages: 761 - 771

    

17. NMR based CSF metabolomics in tuberculous meningitis: correlation with clinical and MRI findings

    • Rashmi Parihar
    • Ruchi Shukla
    • Usha Kant Misra

    Original Article 14 January 2022 Pages: 773 - 785

    

18. Sevoflurane represses the progression of glioma by the regulation of circ_0037655/miR-130a-5p/RPN2 axis

    • Jinyou Zhu
    • Bin Xie
    • Zhenhua Liu

    Original Article 15 January 2022 Pages: 787 - 799

    

19. A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer’s disease

    • R. A. Thuraisingham

    Original Article 15 January 2022 Pages: 801 - 805

20. Knockdown of circ_0007290 alleviates oxygen-glucose deprivation-induced neuronal injury by regulating miR-496/PDCD4 axis

    • Fengjuan Wang
    • Jie Liu
    • Xuhua Jiao

    Original Article 15 January 2022 Pages: 807 - 818

    

21. EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR

    • Xiaoli Li
    • Chengmou Wang
    • Faming Zhou

    Original Article 17 January 2022 Pages: 819 - 833

    

22. Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca²⁺-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior

    • Luiza Spohr
    • Mayara Sandrielly Pereira Soares
    • Roselia Maria Spanevello

    Original Article 19 January 2022 Pages: 835 - 847

    

23. Correction to: RNA as a Source of Biomarkers for Amyotrophic Lateral Sclerosis

    • Lily Kiaei
    • Mahmoud Kiaei

    Correction 31 January 2022 Pages: 849 - 849